Imricor Medical Systems Inc (ASX:IMR)
A$ 0.49 -0.03 (-5.77%) Market Cap: 123.67 Mil Enterprise Value: 137.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Half Year 2020 Imricor Medical Systems Inc Earnings Call Transcript

Aug 24, 2020 / 11:00PM GMT
Release Date Price: A$1.57 (-4.71%)
Operator

Thank you for standing by, and welcome to the Imricor Medical Systems HY '20 Results Investor Briefing. (Operator Instructions) I would now like to hand the conference over to Mr. Steve Wedan, Chair and CEO. Please go ahead.

Steve Wedan
Imricor Medical Systems, Inc. - CEO, President & Executive Chairman

Thank you. Hello, everyone, and thank you for joining us today to discuss the half year results for Imricor. I'm Steve Wedan, Imricor's Chair and CEO, and I'm joined today by our CFO, Lori Milbrandt.

Today, I will take you through Imricor's key achievements during 2020, discuss the impacts of the COVID-19 pandemic and provide you with an update on the business as well as our market and growth opportunities moving forward. Lori will discuss the financial results for the 6 months to 30 June, before I take you through our outlook. We'll then move to a Q&A session.

We started 2020 in an exciting position, achieving a long-awaited CE mark approval, which enabled us to begin to sell our products in the European Union, and we moved swiftly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot